Biochemical markers for severity and risk in GBA and LRRK2 Parkinson's disease.
Thaler A, Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Goldstein O, Kestenbaum M, Cedarbaum JM, Orr-Urtreger A, Shenhar-Tsarfaty S, Mirelman A.
Thaler A, et al. Among authors: goldstein o.
J Neurol. 2021 Apr;268(4):1517-1525. doi: 10.1007/s00415-020-10325-4. Epub 2021 Jan 3.
J Neurol. 2021.
PMID: 33388928